When was Iantrek founded?

Iantrek was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Where is Iantrek located?

Iantrek is headquartered in White Plains, United States.

Who is the current CEO of Iantrek?

Sean Ianchulev of Iantrek. They have also founded 1 company.

How many employees does Iantrek have?

As of Apr 30, 2026, the latest employee count at Iantrek is 76.

Is Iantrek a funded company?

Iantrek is a funded company, having raised a total of $97.8M across 4 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Aug 09, 2022.

When was the latest funding round of Iantrek?

Iantrek's latest funding was a $***** Series C round on Apr 29, 2026, with participation from 1 investor.

Where does Iantrek rank among its competitors?

Iantrek ranks 3rd amongst 34 active competitors, of which 5 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Iantrek, which secured $42M in Aug, 2025.

Who are the top competitors of Iantrek?

Iantrek's top competitors include Alcon, Sight Sciences and Keranova. Among them, Iantrek secured the most recent funding round in April, 2026.

Iantrek - 2026 Company Profile, Team, Funding & Competitors

Iantrek is a series C company based in White Plains (United States), founded in 2019 by Sean Ianchulev. It operates as a Developer of a minimally invasive eye surgery technology. Iantrek has raised $97.8M in funding from investors like USVP, Sectoral and Visionary Ventures. The company has 34 active competitors, including 5 funded and 7 that have exited. Its top competitors include companies like Alcon, Sight Sciences and Keranova.

Company Details

Developer of a minimally invasive eye surgery technology. It offers an implantable biologic stent which is surgically implanted in tandem for increased aqueous outflow and lowering intraocular pressure.

Key Metrics

Founded Year

2019

Location

White Plains, United States

Stage

Series C

Total Funding

$97.8M in 4 rounds

Latest Funding Round

Series C, Apr 29, 2026, $*****

Investors

USVP & 5 more

Ranked

3^rd among 34 active competitors

Employee Count

76 as on Apr 30, 2026

Similar Companies

Alcon & 41 more

View Iantrek's full profile

Iantrek is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Iantrek, Inc. CIN: 83-4247121 , United States, Active	Dec 31, 2018	-	-	-

Iantrek has raised a total funding of $97.8M over 4 rounds. Its first funding round was on Aug 09, 2022. Its latest funding round was a Series C round on Apr 29, 2026 for $*****. 1 investor participated in its latest round. Iantrek has 6 institutional investors.

Here is the list of recent funding rounds of Iantrek:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 29, 2026	6176702	Series C	4562913	3945383	7304931	3704491
Aug 19, 2025	5181914	Series C	1068096	5179646	7672315	Visionary Ventures & 3 more
Feb 14, 2025	1934679	Series B	3279577	6427899	2975370	5225022

Access funding benchmarks and valuations. Sign up today!

View details of Iantrek's funding rounds and investors

The founders of Iantrek is Sean Ianchulev. Sean Ianchulev is the CEO of Iantrek.

Here are the details of Iantrek's key team members:

Sean Ianchulev: Founder & CEO of Iantrek.
Contact Info: 1 email address

Iantrek's Board of Directors

Iantrek's board has 11 active members. Stephen Bloch, James Mazzo, Robert Weinreb, Marc-Andre Marcotte, Jeffrey K. Weinhuff, Tsontcho Ianchulev, Farrell Tyson, Michael George Haydin, IV, Jeffry K Weinhuff, Andrew Corley and Michael Haydin are independent board members.

Here is the list of Iantrek's board of directors:

Name	Type	Representing	Status	Duration
Stephen Bloch	Independent board member	-	Current	5y 5m
q{uf{fd	Independent board member	-	Current	1y 6m
dunnvmi	Independent board member	-	Current	9y 9m
plzvxub	Independent board member	-	Current	9y 8m
utqlomq	Independent board member	-	Current	9y 8m
abnxuyd	Independent board member	-	Current	4y 5m
tjokczf	Independent board member	-	Current	1y 8m
vzucerx	Independent board member	-	Current	9y 5m
{dgyttr	Independent board member	-	Current	5y 1m
chrpkie	Independent board member	-	Current	6y 9m
ge{mzgl	Independent board member	-	Current	1y 3m

View details of Iantrek's Founder profiles and Board Members

Iantrek's employee count trend

Iantrek has 76 employees as of Apr 26. Here is Iantrek's employee count trend over the years:

Uncover Iantrek's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Iantrek include Alcon, Sight Sciences and Keranova. Here is the list of Top 10 competitors of Iantrek, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alcon 1945, Fort Worth (United States), Public	Developer of a wide range of eye care products	$187M	Entrada Ventures, HSBC & 2 others	75/100
2nd	Sight Sciences 2006, Menlo Park (United States), Public	Developer of surgical systems for the treatment of ophthalmological diseases	$129M	Allegro Investment Fund, KCK MedTech & 7 others	63/100
3rd	Iantrek 2019, White Plains (United States), Series C	Developer of a minimally invasive eye surgery technology	$97.8M	Sectoral, aMoon & 4 others	58/100
4th	Keranova 2015, Saint Etienne (France), Series B	Surgical equipment for anterior chamber Ophthalmic surgery	$31M	Supernova Invest, Merieux Developement & 6 others	39/100
5th	Zhitong Technology 2020, Jiaxing (China), Series A	Developer of surgical devices for ophthalmic indications	$13.7M	Aibo Qingshi, Shanlan capital & 2 others	35/100
6th	X-BIOMEDICAL 2017, Wayne (United States), Seed	Revolutionizing microscopy with portable AI & VR systems for healthcare	-	-	32/100
7th	Medicel 1996, Thal (Switzerland), Acquired	Developer of ophthalmic surgical instruments	-	-	32/100
8th	Epsilon Eye Care 1997, Mumbai (India), Unfunded	Manufacturer of ophthalmic precision surgical instruments	-	-	31/100
9th	OSAS Medical 1998, Jeddah (Saudi Arabia), Unfunded	Developer of surgical planning equipment of ophthalmology clinics	-	-	29/100
10th	Cutting Edge 2015, Montpellier (France), Funding Raised	Developer of ophthalmological products	-	IRDI Capital Investissement, SOFILARO	27/100